The company will not receive any proceeds from the sale of the shares by the selling stockholders. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of ...
After hours: January 24 at 6:58:04 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback